Insider filing · MDGL
James M Daly
Director
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 59 filings in 24 months
ticker →
James M Daly sold $5.4M of Madrigal Pharmaceuticals (MDGL)
Executed Feb 27 2025, disclosed Feb 28 2025, 1 day later.
Value, as filed
$5.4M
15,470 sh across 3 lots
Executed
Feb 27 2025
the trade date, as filed
Disclosed
Feb 28 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JDJames M Daly (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $671K of ACAD (30,000 sh × $22.37, as filed), executed Nov 10 2025.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→